Trans-scleral diffusion of triamcinolone acetonide

Current Eye Research

Volumn 30, Issue 5, 2005, Pages 355-361

  Mora, Paolo ^a,b   Eperon, Simone ^a   Felt Baeyens, Olivia ^c   Gurny, Robert ^c   Sagodira, Serge ^d,e   Breton, Pascal ^f   Guex Crosier, Van ^a,g  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d Virsol   (France)

^e Société FIST S A   (France)

^f Immuno Designed Molecules   (France)

^g JULES GONIN EYE HOSPITAL   (Switzerland)

Author keywords

Human; Permeability coefficient; Scleral diffusion; Triamcinolone

Indexed keywords

CORTICOSTEROID; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CELL MEMBRANE PERMEABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DIFFUSION; DRUG PENETRATION; EX VIVO STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SCLERA;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIFFUSION; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; PERMEABILITY; SCLERA; TRIAMCINOLONE ACETONIDE;

EID: 21344447062     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680590934094     Document Type: Article

References (30)

1. Doane MG, Jensen AD, Dohlman CH. Penetration routes of topically applied eye medications. Am J Ophthalmol. 1978;85:383-386.
2. Grass GM, Robinson JR. Mechanism of corneal penetration I: in vivo and in vitro kinetics. J Pharm Sci. 1988;77:3-14.
3. Olsen TW, Edelhauser HF, Lim JI, Gerosky DH. Human scleral permeability. Invest Ophthalmol Vis Sci. 1995;36:1893-1903.
4. Maurice DM, Mishima S. Pharmacology of the eye. In: Sears ML. Handbook of Experimental Pharmacology. Berlin-Heidelberg: Springer-Verlag; 1984;69:19-116.
5. Ahmed I, Gokhale RD, Shah MV, Patton TF. Physicochemical determinants of drug diffusion across the conjunctiva, sciera and cornea. J Pharm Sci. 1987;76:583-586.
6. Prausnitz MR, Noonan J. Permeability of cornea, sciera and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci. 1998;87:1479-1488.
7. Bill A. Movement of albumin and dextran through the sclera. Arch Ophthalmol. 1965;74:248-252.
8. Barza M, Kane A, Baum JL. Regional differences in ocular concentration of gentamicin after subconjunctival and retrobulbar injection in the rabbit. Am J Ophthalmol. 1977;83:407-413.
9. Barza M, Kane A, Baum JL. Intraocular penetration of gentamicin after subconjunctival and retrobulbar injection. Am J Ophthalmol. 1978;85:541-547.
10. McCartney HJ, Drysdale IO, Gornall AG, Basu PK. An autoradiographic study of the penetration of subconjunctivally injected hydrocortisone into normal and inflamed rabbit eye. Invest Ophthalmol Vis Sci. 1965;4:297-302.
11. Madhu C, Rix P, Nguyen T, Chien D.-S, Woodward DF, Tang-Liu DD.-S. Penetration of natural prostaglandins and their ester prodrugs and analogs across human ocular tissues in vitro. J Ocul Pharmacol Ther. 1998;5:389-399.
12. Weijtens O, van der Sluijs FA, Shoemaker RC, Lentjes EG, Cohen AF, Romijn FP, van Meurs JC. Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection. Am J Ophthalmol. 1997;123:358-363.
13. Weijtens O, Shoemaker RC, Cohen AF, Romijn FP, Lentjes EG, van Rooij J, van Meurs JC. Dexamethasone concentration in vitreous arid serum after oral administration. Am J Ophthalmol. 1998;125:673-679.
14. Weijtens O, Feron EJ, Shoemaker RC, Cohen AF, Lentjes EG, Romijn FP, van Meurs JC. High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. Am J Ophthalmol. 1999;128:192-197.
15. Tanner V, Kanski JJ, Frith PA. Posterior sub-Tenon's triamcinolone injections in the treatment of uveitis. Eye. 1998;12:679-685.
16. Grady LT, Hays SE, King RH, Klein HR, Mader WJ, Wyatt DK, Zimmerer RO Jr. Drug purity profiles. J Pharm Sci 1973;62:456-464.
17. Phillips AC, Michniak BB. Transdermal delivery of drugs with differing lipophilicities using azone analogs as dermal penetration enhancers. J Pharm Sci. 1995;84:1427-1433.
18. Franz TJ. On the diffusion of tritiated water through skin. J Invest Dermatol. 1968;50:260.
19. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 2002;109:920-927.
20. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol. 2003;87:24-27.
21. Danis RP, Bingaman DP, Yang Y, Ladd B. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology. 1996;103:2099-2114.
22. Unlu N, Robinson JR. Scleral permeability of hydrocortisone and mannitol in the albino rabbit eye. J Ocul Pharmacol Ther. 1998;14:273-281.
23. Edelhauser HF, Maren TH. Permeability of human cornea and sclera to sulfonamide carbonic anhydrase inhibitors. Arch Ophthalmol. 1988;106:1110-1115.
24. Walker M, Hulme TA, Rippon MG, Walmsley RS, Gunnigle S, Lewin M, Winsey S. In vitro model(s) for the percutaneous delivery of active tissue repair agents. J Pharm Sci. 1997;86:1379-1384.
25. Helm CJ, Holland GN. The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol. 1995;120:55-64.
26. Bamforth SD, Lightman S, Greenwood J. The effect of TNF-alpha and IL 6 on the permeability of the blood-retinal barrier in vivo. Acta Neuropathol. 1996;91:624-632.
27. Luna JD, Chan CC, Derevjanik NL, Mahlow J, Chiu C, Peng B, Tobe T, Campochiaro PA, Vinores SA. Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1 beta-mediated breakdown. J Neurosci Res. 1997;49:268-280.
28. Schoenwald RD, Ward RL. Relationship between steroid permeability across excised rabbit cornea and octanol-water partition coefficients. J Pharm Sci. 1978;67:786-788.
29. Maurice DM, Polgar J. Diffusion across the sclera. Exp Eye Res. 1977;25:577-582.
30. Chien D.-S, Hosmy JJ, Gluchowsky C, Tang-Liu DD.-S. Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes. Curr Eye Res. 1990;9:1051-1059.